EXO Therapeutics

EXO Therapeutics is a biotech company in Boston, United States. It has raised $103.0M across 2 rounds, most recently a $78.0M Series B in October 2021.

Exo Therapeutics, Inc.

Business Model
B2B
Total Funding
$103.0M
Last Round
$78.0M Series BOct 2021
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 8 investors for this company. The full record is or through the API.

About

Exo Therapeutics is a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets. By leveraging the company’s ExoSight platform, it develops potent drug candidates that bind exosites, distal and unique binding pockets that have the potential to reprogram enzyme activity for precise and robust therapeutic effect. While roughly 10,000 proteins are involved in human disease, only about 700 are currently accessible as pharmaceutical targets; Exo aims to expand that druggable universe. Its scientific approach is based on research from the labs of Drs. David Liu and Alan Saghetelian following their discovery of non-active site inhibitors that selectively reprogram Insulin Degrading Enzyme, unlocking breakthrough therapeutics in oncology, inflammation, and other diseases.

Summary

It has raised $103.0M in total across 2 rounds, most recently a $78.0M Series B round in Oct 2021. Investors include Newpath Management, Novartis Venture Fund and CRV (Charles River).

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BOct 2021
$78.0M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

EXO Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/exo-therapeutics"><img src="https://indexed.vc/api/badge/company/exo-therapeutics" alt="EXO Therapeutics on Indexed.vc" width="260" height="76" /></a>